• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “affinivax” Archives

          in
          Entry Author Date Location
          Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More Frank Vinluan 04/24/20 National
          Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory Frank Vinluan 04/23/20 Boston
          SutroVax Lands $64M From Roche, Others to Back Vaccine Studies Frank Vinluan 03/21/17 San Francisco
          Bio Roundup: Healthcare Is Hard, “Slow” FDA, Drugging RNA & More Alex Lash 03/03/17 National
          Affinivax Obtains $2,500,000 New Funding Round VentureDeal 02/05/16 Boston
          Genocea Ditches Pneumococcus Vaccine After Phase 2 Flop, Shares Fall Ben Fidler 10/19/15 Boston
          East Coast Biotech Roundup: Genzyme, 21st Century Cures, Acorda, & More Ben Fidler 02/13/15 Boston
          Accelerate LI’s Latest Startup Aims to Rewire Viruses With Software Ben Fidler 12/16/14 New York
          East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More Ben Fidler 10/31/14 Boston
          Affinivax Garners $4,000,000 New Round VentureDeal 10/31/14 Boston
          Backed by Gates, Affinivax Ramps up Velcro-like Vaccine Tech Ben Fidler 10/30/14 Boston
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • Xcelerating Life Sciences San Francisco: Special Report

            From Our Editors · Special Report

            Xcelerating Life Sciences San Francisco: Special Report

            The AI, Big Data, and R&D Boom

          • Xcelerating Life Sciences San Francisco: The Highlights Podcast

            From Our Editors · Podcast

            Xcelerating Life Sciences San Francisco: The Highlights Podcast

            The AI, Big Data, and R&D Boom

          • How Healthy Are Your Market Access Programs?

            Sponsored · Whitepaper

            How Healthy Are Your Market Access Programs?

            A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs

            Archbow Consulting

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.